Main > > >ONCOLOGY>MYELOFIBROSIS. *

---

TREAT.: Fedratinib Capsules.
JAK2 Inhibitor.
CA Approval Date: 2020. 09.21.
EU Approval Date: 2021. 02.08.
USA Approval Date: 2019. 08.16.
(*) Companies; Patent; TradeMark & Web-
Site Available on Request.
UpDate: 2021. 02.14.




TREAT.: Ruxolitinib Tablets.
JAK 1/2 Inhibitor.
USA Approval Date: 2011. 11.16.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2018. 11.21.



>ONCOLOGY>MYELOFIBROSIS. *'s products
This section has no products